TrialNagoya journal of medical science2017

Fixed-dose combination of alogliptin/pioglitazone improves glycemic control in Japanese patients with type 2 diabetes mellitus independent of body mass index.

Chie Aoki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.